Literature DB >> 17878400

Differential costimulation through CD137 (4-1BB) restores proliferation of human virus-specific "effector memory" (CD28(-) CD45RA(HI)) CD8(+) T cells.

Edward C P Waller1, Nicola McKinney, Ray Hicks, Andrew J Carmichael, J G Patrick Sissons, Mark R Wills.   

Abstract

In healthy carriers of human cytomegalovirus (HCMV), the virus-specific memory CD8(+) T-cell population is often dominated by CD28(-) CD45RA(hi) cells that exhibit direct ex vivo cytotoxicity but whose capacity for proliferation and generation of further memory cells has been questioned. We show that when highly purified CD28(-) CD45RA(hi) CD8(+) T cells are stimulated with viral peptide presented by autologous monocytes, the virus-specific T cells show early up-regulation of CD137 (4-1BB) and CD278 (ICOS), re-express CD28, and proliferate with similarly high cloning efficiency in limiting dilution analysis as CD28(+) CD45RO(hi) cells or CD28(-) CD45RO(hi) cells. Using peptide-pulsed autologous fibroblasts transfected with individual costimulatory ligands as antigen presenting cells, we showed CD137L to be a key costimulatory ligand for proliferation of CD28(-) CD45RA(hi) CD8(+) T cells and not CD80, CD86, or CD275 (ICOSL). Therefore, CD28(-) CD45RA(hi) CD8(+) T cells were not terminally differentiated but required a specific costimulatory signal for proliferation.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17878400     DOI: 10.1182/blood-2007-07-104604

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  36 in total

Review 1.  KLRG1--more than a marker for T cell senescence.

Authors:  Sian M Henson; Arne N Akbar
Journal:  Age (Dordr)       Date:  2009-12

2.  Intrinsic TGF-β signaling promotes age-dependent CD8+ T cell polyfunctionality attrition.

Authors:  Rajarshi Bhadra; Magali M Moretto; Julio C Castillo; Constantinos Petrovas; Sara Ferrando-Martinez; Upasana Shokal; Manuel Leal; Richard A Koup; Ioannis Eleftherianos; Imtiaz A Khan
Journal:  J Clin Invest       Date:  2014-04-24       Impact factor: 14.808

Review 3.  The impact of inflationary cytomegalovirus-specific memory T cells on anti-tumour immune responses in patients with cancer.

Authors:  Xiao-Hua Luo; Qingda Meng; Martin Rao; Zhenjiang Liu; Georgia Paraschoudi; Ernest Dodoo; Markus Maeurer
Journal:  Immunology       Date:  2018-09-10       Impact factor: 7.397

Review 4.  Buffered memory: a hypothesis for the maintenance of functional, virus-specific CD8(+) T cells during cytomegalovirus infection.

Authors:  Christopher M Snyder
Journal:  Immunol Res       Date:  2011-12       Impact factor: 2.829

5.  4-1BB signaling synergizes with programmed death ligand 1 blockade to augment CD8 T cell responses during chronic viral infection.

Authors:  Vaiva Vezys; Pablo Penaloza-MacMaster; Daniel L Barber; Sang-Jun Ha; Bogumila Konieczny; Gordon J Freeman; Robert S Mittler; Rafi Ahmed
Journal:  J Immunol       Date:  2011-07-08       Impact factor: 5.422

6.  Human cytomegalovirus-specific CD8(+) T-cell expansions contain long-lived cells that retain functional capacity in both young and elderly subjects.

Authors:  Diana L Wallace; Joanne E Masters; Catherine M De Lara; Sian M Henson; Andrew Worth; Yan Zhang; Shikha R Kumar; Peter C Beverley; Arne N Akbar; Derek C Macallan
Journal:  Immunology       Date:  2010-08-25       Impact factor: 7.397

7.  Memory inflation during chronic viral infection is maintained by continuous production of short-lived, functional T cells.

Authors:  Christopher M Snyder; Kathy S Cho; Elizabeth L Bonnett; Serani van Dommelen; Geoffrey R Shellam; Ann B Hill
Journal:  Immunity       Date:  2008-10-17       Impact factor: 31.745

8.  A novel form of 4-1BBL has better immunomodulatory activity than an agonistic anti-4-1BB Ab without Ab-associated severe toxicity.

Authors:  Rich-Henry Schabowsky; Kutlu G Elpek; Shravan Madireddi; Rajesh K Sharma; Esma S Yolcu; Laura Bandura-Morgan; Robert Miller; Kathryn J MacLeod; Robert S Mittler; Haval Shirwan
Journal:  Vaccine       Date:  2009-10-29       Impact factor: 3.641

9.  Biphasic role of 4-1BB in the regulation of mouse cytomegalovirus-specific CD8(+) T cells.

Authors:  Ian R Humphreys; Seung-Woo Lee; Morgan Jones; Andrea Loewendorf; Emma Gostick; David A Price; Chris A Benedict; Carl F Ware; Michael Croft
Journal:  Eur J Immunol       Date:  2010-10       Impact factor: 5.532

Review 10.  ProtEx technology for the generation of novel therapeutic cancer vaccines.

Authors:  Rich-Henry Schabowsky; Rajesh K Sharma; Shravan Madireddi; Abhishek Srivastava; Esma S Yolcu; Haval Shirwan
Journal:  Exp Mol Pathol       Date:  2009-01-31       Impact factor: 3.362

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.